Marco Fossati

Interleukin‐21 (<scp>IL</scp>‐21) synergizes with <scp>IL</scp>‐2 to enhance <scp>T</scp>‐cell receptor‐induced human T‐cell proliferation and counteracts <scp>IL</scp>‐2/transforming growth factor‐β‐induced regulatory T‐cell development

Alessandra Battaglia, Alexia Buzzonetti, Cinzia Baranello et al. · Immunology · 2012 · 49 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Absence of VOD in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous Busulphan

Barbara Cappelli, Robert Chiesa, Costanza Evangelio et al. · British Journal of Haematology · 2009 · 46 citations

Medicine, Hematology, Pharmacotherapy +9

Unpredictability of Intravenous Busulfan Pharmacokinetics in Children Undergoing Hematopoietic Stem Cell Transplantation for Advanced Beta Thalassemia: Limited Toxicity with a Dose-Adjustment Policy

Robert Chiesa, Barbara Cappelli, Roberto Crocchiolo et al. · Biology of Blood and Marrow Transplantation · 2009 · 38 citations · Full text

Pharmacy, Hematology, Pharmacokinetics +15

Immunological changes in the ascites of cancer patients after intraperitoneal administration of the bispecific antibody catumaxomab (anti-EpCAM×anti-CD3)

Marco Fossati, Alexia Buzzonetti, Giovanni Monego et al. · Gynecologic Oncology · 2015 · 28 citations

Medicine, Immunology, Oncology +15

Escalating doses of donor lymphocytes for incipient graft rejection following SCT for thalassemia

Ilaria Frugnoli, Barbara Cappelli, Robert Chiesa et al. · Bone Marrow Transplantation · 2009 · 26 citations

Life Sciences, Hematology, Immunology +14